Connecticut § 19a-111g Pediatric lead testing and risk assessment. Exemption. Prenatal guidance. Local health director epidemiological investigations.

Connecticut Statutes

§ 19a-111g — Pediatric lead testing and risk assessment. Exemption. Prenatal guidance. Local health director epidemiological investigations.

Connecticut·Title 19a Public Health and Well-Being·Ch. 368a Department of Public Health

(a)(1) Each primary care provider giving pediatric care in this state, excluding a hospital emergency department and its staff shall conduct lead risk assessment and lead testing that includes, but need not be limited to:

(A)A complete medical risk assessment based on guidelines prescribed by the commissioner for each child from birth to six years of age, conducted at least annually;

(B)An annual lead screening test for each child who has an elevated risk of lead exposure based on findings of the medical risk assessment conducted pursuant to subparagraph (A) of this subdivision;

(C)A lead screening test for each child at twelve months of age and twenty-four months of age; and (D) Follow-up testing, in accordance with a schedule established by the commissioner, for each child with a conf

Free access — add to your briefcase to read the full text and ask questions with AI

(a)(1) Each primary care provider giving pediatric care in this state, excluding a hospital emergency department and its staff shall conduct lead risk assessment and lead testing that includes, but need not be limited to: (A) A complete medical risk assessment based on guidelines prescribed by the commissioner for each child from birth to six years of age, conducted at least annually; (B) An annual lead screening test for each child who has an elevated risk of lead exposure based on findings of the medical risk assessment conducted pursuant to subparagraph (A) of this subdivision; (C) A lead screening test for each child at twelve months of age and twenty-four months of age; and (D) Follow-up testing, in accordance with a schedule established by the commissioner, for each child with a confirmed blood lead level equal to or greater than three and one-half micrograms per deciliter. (2) Each primary care provider giving pediatric care in this state, excluding a hospital emergency department and its staff, shall provide educational materials and guidance information concerning lead poisoning prevention to each child's parent or guardian in accordance with the commissioner's recommendations for childhood lead screening. (3) The requirements of this subsection shall not apply to any child whose parents or guardians object to blood testing as being in conflict with their religious tenets and practice. (b) Each prenatal health care provider shall (1) provide each pregnant person anticipatory guidance on lead poisoning prevention during pregnancy, (2) assess each pregnant person at the initial prenatal visit for lead exposure using a risk assessment tool recommended by the commissioner, (3) screen or refer for blood lead screening each pregnant person found to be at risk for lead exposure, (4) notify the local health director serving the jurisdiction in which the pregnant person resides if such person has a blood lead level equal to or greater than three and one-half micrograms per deciliter, and (5) provide anticipatory guidance regarding the prevention of childhood lead poisoning to each patient at such patient's postpartum visit. (c) Upon the receipt of any notice provided pursuant to subdivision (4) of subsection (b) of this section, a local health director shall conduct the epidemiological investigation and take such other actions as described in section 19a-111 .

Connecticut § 19a-111g (Pediatric lead testing and risk assessment. Exemption. Prenatal guidance. Local health director epidemiological investigations.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

(June Sp. Sess. P.A. 07-2, S. 48; P.A. 14-231, S. 9; P.A. 22-49, S. 3; 22-118, S. 151; P.A. 23-31, S. 35.) History: June Sp. Sess. P.A. 07-2 effective January 1, 2009; P.A. 14-231 amended Subsec. (a) by replacing “screening” with “testing” and making a conforming change, adding new Subdiv. (3) re educational materials and anticipatory guidance information, redesignating existing Subdiv. (3) re medical risk assessment as Subdiv. (4) and amending same by replacing “seventy-one” with “seventy-two”, and redesignating existing Subdiv. (4) as Subdiv. (5); P.A. 22-49 amended Subsec. (a) by replacing reference to “Childhood Lead Poisoning Prevention Screening Advisory Committee” with “Advisory Committee on Childhood Lead Poisoning Prevention” in Subdiv. (1), adding new Subdiv. (2) re annual lead testing for a child 36 to 72 months of age determined to be at an elevated risk of lead exposure and redesignating existing Subdivs. (2) to (5) as Subdivs. (3) to (6), effective January 1, 2023; P.A. 22-118 made identical changes as P.A. 22-49, effective January 1, 2023; P.A. 23-31 amended Subsec. (a) by deleting Subdivs. (1) to (6) re pediatric lead testing criteria, adding new Subdiv. (1) re lead risk assessment and lead testing program, adding new Subdiv. (2) re educational materials and guidance information, redesignated existing Subsec. (b) as Subsec. (a)(3) and made a technical change in same, added new Subsec. (b) re requirements of prenatal health care providers, and added Subsec. (c) re local health director epidemiological investigation, effective January 1, 2024.